Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform

26 April 2023

Pharmaphorum – Why ‘reduce, reuse, and recycle’ medicine is the future

19 April 2023

Open

POLITICO – Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)

17 January 2023

Can the European Union bring eye-wateringly expensive medicines to the […]

Billions more euros to re-invest in better healthcare thanks to biosimilar medicines

13 December 2022

Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies

16 November 2022

Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022